Cart
sales@molnova.com
Nabumetone
CAS No. 42924-53-8
Nabumetone( BRL 14777 )
Catalog No. M14456 CAS No. 42924-53-8
Nabumetone(BRL14777) is a non-steroidal anti-inflammatory drug and its active metabolite inhibits the COX.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | 46 | In Stock |
|
Biological Information
-
Product NameNabumetone
-
NoteResearch use only, not for human use.
-
Brief DescriptionNabumetone(BRL14777) is a non-steroidal anti-inflammatory drug and its active metabolite inhibits the COX.
-
DescriptionNabumetone(BRL14777) is a non-steroidal anti-inflammatory drug and its active metabolite inhibits the COX.(In Vitro):Nabumetone is a potent and selective COX-2 inhibitor. Nabumetone (50 μmol-2 mmol) dose-dependently inhibits the proliferation of K-562 and Meg-01 cells, but shows no obvious apoptotic effect. Nabumetone potentiates the apoptotic effect of ADR in the K-562 cell line. Moreover, Nabumetone reduces Bcl-2 expression. (In Vivo):Nabumetone (79 mg/kg, p.o.) inhibits paw oedema and paw exudate PGE2 in rats. Nabumetone does not induce gastric damage and causes only 57% inhibition of gastric mucosal 6-keto-PGF1α production in rats. Nabumetone (25, 50, 100 mg/kg, i.p.) dose-dependently inhibits the increase of DDC-induced mucus secretion and stimulates stress-induced mucus secretion in rats. Nabumetone (25 mg/kg, i.p.) significantly suppresses stress-induced ulcer index in rats.
-
In VitroNabumetone is a potent and selective COX-2 inhibitor. Nabumetone (50 μmol-2 mmol) dose-dependently inhibits the proliferation of K-562 and Meg-01 cells, but shows no obvious apoptotic effect. Nabumetone potentiates the apoptotic effect of ADR in the K-562 cell line. Moreover, Nabumetone reduces Bcl-2 expression.
-
In VivoNabumetone (79 mg/kg, p.o.) inhibits paw oedema and paw exudate PGE2 in rats. Nabumetone does not induce gastric damage and causes only 57% inhibition of gastric mucosal 6-keto-PGF1α production in rats. Nabumetone (25, 50, 100 mg/kg, i.p.) dose-dependently inhibits the increase of DDC-induced mucus secretion and stimulates stress-induced mucus secretion in rats. Nabumetone (25 mg/kg, i.p.) significantly suppresses stress-induced ulcer index in rats.
-
SynonymsBRL 14777
-
PathwayChromatin/Epigenetic
-
TargetCOX
-
RecptorCOX-1| COX-2| MPO
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number42924-53-8
-
Formula Weight228.29
-
Molecular FormulaC15H16O2
-
Purity>98% (HPLC)
-
SolubilityEthanol: 25 mg/mL (109.5 mM); DMSO: 46 mg/mL (201.49 mM)
-
SMILESCC(CCC1=CC=C2C=C(OC)C=CC2=C1)=O
-
Chemical Name4-(6-methoxynaphthalen-2-yl)butan-2-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Hedner T, et al. Drugs, 2004, 64(20), 2315-2343.
molnova catalog
related products
-
(R)-Flurbiprofen
A non-steroidal anti-inflammatory drug (NSAID); primarily indicated as a pre-operative anti-miotic as well as orally for arthritis or dental pain; cyclooxygenase (COX) inhibitor.
-
Eltenac
Eltenac (B78820) is a non-steroidal anti-inflammatory, COX inhibitor with analgesic activity.Eltenac inhibits COX-1 and COX-2 and is used in the study of Acute Respiratory Distress Syndrome (ARDS).
-
Hirsutanonol
Hirsutanonol is a secondary metabolite from the bark of Alnus glutinosa. Hirsutanonol has potent antioxidant and free radical scavenging activities and exhibits an inhibition effect on mitochondrial lipid peroxidation. Hirsutanonol can be used for studies
